The Xmn1 polymorphic site 5' to the Gγ gene and its correlation to the Gγ:Aγ ratio, age at first blood transfusion and clinical features in β-Thalassemia patients from Western Iran

被引:25
作者
Nemati, Hooshang [1 ]
Rahimi, Zohreh [2 ,3 ]
Bahrami, Gholamreza [4 ]
机构
[1] Kermanshah Univ Med Sci, Sch Pharm, Dept Biochem, Kermanshah, Iran
[2] Kermanshah Univ Med Sci, Sch Med, Med Biol Res Ctr, Kermanshah, Iran
[3] Kermanshah Univ Med Sci, Sch Med, Dept Biochem, Kermanshah, Iran
[4] Kermanshah Univ Med Sci, Sch Pharm, Dept Pharmacol, Kermanshah, Iran
关键词
Thalassemia; (G)gamma chain percent; Xmn1 polymorphic site; Splenectomy; Facial bone deformity; Age at first blood transfusion; FETAL-HEMOGLOBIN; HYDROXYUREA; EXPRESSION; INTERMEDIA; THERAPY; DISEASE;
D O I
10.1007/s11033-009-9566-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Thalassemia is the most common single gene disorder in Iran and more than 25,000 affected individuals have been reported. It has been reported that in patients with beta-thalassemia in the presence of Xmn1 polymorphic site the level of Hb F and (G)gamma: (A)gamma ratio is increased. The prevalence of Xmn1 polymorphic site, (G)gamma: (A)gamma ratio and Hb F in 197 beta-thalassemia major patients from the Kermanshah Province of Iran were studied. The Xmn1 polymorphic site was determined by PCR-RFLP procedure. The levels of (G)gamma and (A)gamma chains were detected by HPLC. The percent of Hb F was determined using electrophoresis method. In beta-thalassemia major patients the frequency of presence Xmn1 was 0.39. The mean of (G)gamma: (A)gamma ratio was found to be 2.5. In the present study it was found that in the presence of Xmn1 polymorphic site (G)gamma percent and (G)gamma: (A)gamma ratio were significantly increased (P = 0.01) and the clinical features such as splenomegaly and bone marrow expansion were significantly improved (P = 0.01). We found that in the presence of Xmn1 polymorphic site on both chromosomes (+/+) the level of Hb F tended to be increased compared to the absence of Xmn1 (-/-). The present investigation has studied the frequency of Xmn1 polymorphic site in beta-thalassemia major patients from Western Iran and has revealed that the presence of this polymorphic site caused a positive influence on Hb F production and the (G)gamma percent which could improve the clinical symptoms of beta-thalassemia patients.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 35 条
[1]   Hydroxyurea in the treatment of major β-thalassemia and importance of genetic screening [J].
Alebouyeh, M ;
Moussavi, F ;
Haddad-Deylami, H ;
Vossough, P .
ANNALS OF HEMATOLOGY, 2004, 83 (07) :430-433
[2]   Successful use of hydroxyurea in beta-thalassemia major [J].
Arruda, VR ;
Lima, CSP ;
Saad, STO ;
Costa, FF .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :964-964
[3]   THE XMN-I SITE (-158, C-]T) 5' TO THE G-GAMMA-GENE - CORRELATION WITH THE SENEGALESE HAPLOTYPE AND G-GAMMA-GLOBIN EXPRESSION [J].
BALLAS, SK ;
TALACKI, CA ;
ADACHI, K ;
SCHWARTZ, E ;
SURREY, S ;
RAPPAPORT, E .
HEMOGLOBIN, 1991, 15 (05) :393-405
[4]   MANAGEMENT OF THALASSEMIA MAJOR BY PARTIAL SPLENECTOMY [J].
BANANI, SA ;
BAHADOR, A .
PEDIATRIC SURGERY INTERNATIONAL, 1994, 9 (5-6) :350-352
[5]   Variable severity of β-thalassemia patients of Eastern India:: effect of α-thalassemia and Xmnl polymorphism [J].
Bandyopadhyay, S ;
Roychowdhury, K ;
Chandra, S ;
Das, M ;
Dasgupta, UB .
CLINICAL AND EXPERIMENTAL MEDICINE, 2001, 1 (03) :155-159
[6]  
BORGNEPIGNATLI G, 2004, WINTROBES CLIN HEMAT, P1319
[7]   EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].
CHARACHE, S ;
TERRIN, ML ;
MOORE, RD ;
DOVER, GJ ;
BARTON, FB ;
ECKERT, SV ;
MCMAHON, RP ;
BONDS, DR ;
ORRINGER, E ;
JONES, S ;
STRAYHORN, D ;
ROSSE, W ;
PHILLIPS, G ;
PEACE, D ;
JOHNSONTELFAIR, A ;
MILNER, P ;
KUTLAR, A ;
TRACY, A ;
BALLAS, SK ;
ALLEN, GE ;
MOSHANG, J ;
SCOTT, B ;
STEINBERG, M ;
ANDERSON, A ;
SABAHI, V ;
PEGELOW, C ;
TEMPLE, D ;
CASE, E ;
HARRELL, R ;
CHILDERIE, S ;
EMBURY, S ;
SCHMIDT, B ;
DAVIES, D ;
KOSHY, M ;
TALISCHYZAHED, N ;
DORN, L ;
PENDARVIS, G ;
MCGEE, M ;
TELFER, M ;
DAVIS, A ;
CASTRO, O ;
FINKE, H ;
PERLIN, E ;
SITEMAN, J ;
GASCON, P ;
DIPAOLO, P ;
GARGIULO, S ;
ECKMAN, J ;
BAILEY, JH ;
PLATT, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322
[8]   AN IMPROVED METHOD FOR CHARACTERIZATION OF HUMAN HAEMOGLOBIN MUTANTS - IDENTIFICATION OF ALPHA2BETA295GLU HAEMOGLOBIN N (BALTIMORE) [J].
CLEGG, JB ;
NAUGHTON, MA ;
WEATHERALL, DJ .
NATURE, 1965, 207 (5000) :945-+
[9]  
FAIRBANKS VF, 1994, TIETZ TXB CLIN CHEM, P2041
[10]   Pharmacological induction of fetal hemoglobin - Why haven't we been more successful in thalassemia? [J].
Fathallah, H ;
Sutton, M ;
Atweh, GF .
COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 :228-237